Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets

NCT00499824 is registered in ClinicalTrials.gov with International Diabetes Institute, Australia as lead sponsor.

NCT NCT00499824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00499824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets
Lead sponsor
International Diabetes Institute, Australia
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2007
Completion date
February 28, 2009
Enrollment
386 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus